Literature DB >> 12076310

Treatment of distal colitis with local anaesthetic agents.

Stellan Björck1, Annica Dahlström, Håkan Ahlman.   

Abstract

The results of clinical and experimental studies on topical treatment of distal colitis with local anaesthetic agents are summarized. The original observation was an adrenergic hyperinnervation of the inflamed mucosa (hyperinnervation hypothesis). In order to silence local nervous reflexes, the mucosa was treated topically with 2% lidocaine gel. The clinical results are promising and no side effects have been observed. The relapse rate is relatively high and related to the duration of treatment. In studies of experimental colitis a potential antagonism between harmful adrenergic nerves (vasoconstrictor substances and proinflammatory cytokines) and mucosa-protective visceral afferents (antiinflammatory cytokines) in the pathogenesis of colitis is intriguing. Other studies have emphasized the importance of neutrophils for causing damage to the colon epithelium (neutrophil hypothesis) and local anaesthetics have potent effects on several steps of the inflammatory response in addition to the nervous blockade.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076310     DOI: 10.1034/j.1600-0773.2002.900401.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  10 in total

Review 1.  Medical approaches and future options in chronic active ulcerative colitis.

Authors:  J T Siveke; C Folwaczny
Journal:  Int J Colorectal Dis       Date:  2004-01-15       Impact factor: 2.571

Review 2.  ["Alternative" effects of local anesthetic agents].

Authors:  S Pecher; B W Böttiger; B Graf; M W Hollmann
Journal:  Anaesthesist       Date:  2004-04       Impact factor: 1.041

3.  Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model.

Authors:  Ugur Duman; Aysun Yilmazlar; Ersin Ozturk; Sibel Aker; Emre Sarandol; Tuncay Yilmazlar
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

4.  Systemic lidocaine and mexiletine for the treatment of a patient with total ulcerative colitis.

Authors:  Y Yokoyama; S Onishi
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 5.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 6.  Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation.

Authors:  Ashkan Farhadi; Jeremy-Z Fields; Ali Keshavarzian
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

7.  Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation.

Authors:  A Lahat; S Ben-Horin; S B Horin; A Lang; E Fudim; O Picard; Y Chowers
Journal:  Clin Exp Immunol       Date:  2008-03-18       Impact factor: 4.330

8.  Enteric neurones modulate the colonic permeability response to luminal bile acids in rat colon in vivo.

Authors:  Y Sun; B-M Fihn; H Sjövall; M Jodal
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

9.  Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord.

Authors:  Yan Zhang; Gao-Jian Tao; Liang Hu; Jie Qu; Yuan Han; Guangqin Zhang; Yanning Qian; Chun-Yi Jiang; Wen-Tao Liu
Journal:  J Neuroinflammation       Date:  2017-11-02       Impact factor: 8.322

10.  Anti-Inflammatory Characteristics of Local Anesthetics: Inhibition of TNF-α Secretion of Lipopolysaccharide-Stimulated Leucocytes in Human Blood Samples.

Authors:  Stefan Weinschenk; Carsten Weiss; Justus Benrath; Volker von Baehr; Thomas Strowitzki; Manuel Feißt
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.